During the past decade, Quality Care Research conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Quality Care Research" #1 collaborator was "Brigham and Women's Hospital" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Quality Care Research" are "Cardiovascular Disease" (2 trials), "Dyslipidemia" (1 trials) and "Type2 Diabetes" (1 trials). Many other conditions were trialed in "Quality Care Research" in a lesser frequency.

Most popular intervention types in "Quality Care Research" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "bococizumab (PF-04950615)" (2 trials) and "K-877" (1 trials). Other intervention names were less common.

The vast majority of trials in "Quality Care Research" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Quality Care Research". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Quality Care Research, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Quality Care Research, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".